HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pathogenesis and treatment of anoxic encephalopathy. Definition and importance of experimental animal models (author's transl)].

Abstract
A reproducible noninvasive monkey model for global brain ischemia with exact insult (no flow x 16 min) to the brain, with survival and with standardized preischemic, ischemic and postischemic variables is described. This model allowed us to demonstrate for the first time: 1) that a substantial part of brain damage early postischemia is reversible and amenable especially to barbiturate treatment; 2) that the postischemic brain shows increased vulnerability for additional insults. Optimal postischemic intensive monitoring and immobilization for 24-48 hours is important for improved outcome; 3) that immediate postischemic reperfusion pressure (MAP 110-150 mm Hg) significantly improves the outcome; 4) that heparinisation during ischemia has no protective effect and 5) that postischemic heparinisation and intravenous hemodilution does not ameliorate the outcome. The protective effect of trimetaphan against neurogenic pulmonary edema can be explained by the prevention of pulmonary hypertension but its protective effect on the development of secondary cerebral edema has to be elucidated.
AuthorsA L Bleyaert, B Kuperwasser, J L Chang, N Cohn, J A Willy, E M Nemoto
JournalAnesthesie, analgesie, reanimation (Anesth Analg (Paris)) Vol. 37 Issue 9-10 Pg. 543-7 ( 1980) ISSN: 0003-3014 [Print] France
Vernacular TitlePathogénie et traitement de l'encéphalopathie anoxique. Définition et utilité des modèles expérimentaux animaux.
PMID7469071 (Publication Type: English Abstract, Journal Article)
Topics
  • Animals
  • Disease Models, Animal
  • Ischemic Attack, Transient (pathology, therapy)
  • Macaca mulatta

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: